Investors eying income solutions and defense stocks as geopolitical tensions rise
(This is a wrap-up of the key money moving discussions on CNBC’s “Worldwide…
Biotech is an overlooked way to benefit from lower rates, Goldman says
As investors await the Federal Reserve rate decision Wednesday afternoon, Goldman Sachs highlighted…
Move over Big Tech, a new market leader could be emerging, according to the charts
While the dominance of megacap growth stocks has been a key factor in the latest bull run for…
The winning themes of 2023 could mature and keep climbing next year, BlackRock says
Investors don’t need to abandon the themes that worked in 2023 just because the calendar is…
One beaten up part of commercial real estate could be a bright spot
As the market reassesses the value of office properties, investors have been steering clear of many…
Biotechs that could rally 35%+ include one targeting Schizophrenia
With new drug launches and product approvals on the horizon, some biotechnology stocks could finally…
Biotech stocks to buy that look cheap with large upside: Screen
U.S. biotech stocks have been on the up recently. The S & P Biotechnology Select Industry Index…
These ETFs can help round out your midterm election investing playbook
Wall Street appears to be cautiously optimistic about this week’s midterm elections, with the…
The market could be anticipating a Republican sweep of Congress in Tuesday’s election
Stocks that would benefit from Republican policies have been moving higher, signaling that traders…
